132 related articles for article (PubMed ID: 9049842)
1. Menadione inhibits MIBG uptake in two neuroendocrine cell lines.
Cornelissen J; Tytgat GA; van den Brug M; van Kuilenburg AB; Voûte PA; van Gennip AH
J Neurooncol; 1997 Jan; 31(1-2):147-51. PubMed ID: 9049842
[TBL] [Abstract][Full Text] [Related]
2. HBO and the uptake and retention of [125I] MIBG in human platelets and two neuroendocrine cell lines.
Tytgat GA; Cornelissen J; Van den Brug M; Van Kuilenburg AB; Voute PA; Van der Kleij AJ; Van Gennip AH
Anticancer Res; 1997; 17(2A):1209-12. PubMed ID: 9137473
[TBL] [Abstract][Full Text] [Related]
3. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
[TBL] [Abstract][Full Text] [Related]
4. Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells.
Babich JW; Graham W; Fischman AJ
Eur J Nucl Med; 1997 May; 24(5):538-43. PubMed ID: 9142735
[TBL] [Abstract][Full Text] [Related]
5. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
[TBL] [Abstract][Full Text] [Related]
6. Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells.
Smets LA; Janssen M; Metwally E; Loesberg C
Biochem Pharmacol; 1990 Jun; 39(12):1959-64. PubMed ID: 2353937
[TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
Montaldo PG; Carbone R; Lanciotti M; Ponzoni M; Cornaglia-Ferraris P
J Nucl Biol Med (1991); 1991; 35(4):195-8. PubMed ID: 1823817
[TBL] [Abstract][Full Text] [Related]
8. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
Armour A; Mairs RJ; Gaze MN; Wheldon TE
Br J Cancer; 1994 Sep; 70(3):445-8. PubMed ID: 8080728
[TBL] [Abstract][Full Text] [Related]
9. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
Smets LA; Rutgers M
J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
Smets LA; Janssen M; Rutgers M; Ritzen K; Buttenhuis C
Int J Cancer; 1991 Jun; 48(4):609-15. PubMed ID: 2045205
[TBL] [Abstract][Full Text] [Related]
11. Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
Strickland DK; Vaidyanathan G; Friedman HS; Zalutsky MR
J Neurooncol; 1995; 25(1):9-17. PubMed ID: 8523094
[TBL] [Abstract][Full Text] [Related]
12. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
Gaze MN; Hamilton TG; Mairs RJ
Br J Radiol; 1994 Jun; 67(798):573-8. PubMed ID: 8032811
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
15. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Mastrangelo R
Cancer Res; 1993 Jan; 53(2):304-9. PubMed ID: 8417824
[TBL] [Abstract][Full Text] [Related]
16. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
Lashford LS; Hancock JP; Kemshead JT
Int J Cancer; 1991 Jan; 47(1):105-9. PubMed ID: 1985865
[TBL] [Abstract][Full Text] [Related]
17. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
Montaldo PG; Raffaghello L; Guarnaccia F; Pistoia V; Garaventa A; Ponzoni M
Int J Cancer; 1996 Jul; 67(1):95-100. PubMed ID: 8690531
[TBL] [Abstract][Full Text] [Related]
18. Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.
Kölby L; Bernhardt P; Levin-Jakobsen AM; Johanson V; Wängberg B; Ahlman H; Forssell-Aronsson E; Nilsson O
Br J Cancer; 2003 Oct; 89(7):1383-8. PubMed ID: 14520475
[TBL] [Abstract][Full Text] [Related]
19. Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
Rutgers M; Tytgat GA; Verwijs-Janssen M; Buitenhuis C; Voûte PA; Smets LA
Int J Cancer; 1993 May; 54(2):290-5. PubMed ID: 8486431
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
Montaldo PG; Lanciotti M; Casalaro A; Cornaglia-Ferraris P; Ponzoni M
Cancer Res; 1991 Aug; 51(16):4342-6. PubMed ID: 1868458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]